BML Investment Partners L.P. 13D and 13G filings for Metacrine, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-02-08 3:43 pm Purchase | 2023-02-08 | 13G | Metacrine, Inc. MTCR | BML Investment Partners L.P. | 6,767,458 15.900% | 278,493![]() (+4.29%) | Filing |
2022-12-08 12:08 pm Purchase | 2022-12-08 | 13D | Metacrine, Inc. MTCR | BML Investment Partners L.P. | 6,488,965 15.200% | 976,799![]() (+17.72%) | Filing |
2022-10-26 5:59 pm Purchase | 2022-10-24 | 13G | Metacrine, Inc. MTCR | BML Investment Partners L.P. | 5,512,166 12.900% | 3,912,166![]() (+244.51%) | Filing |
2022-02-17 8:27 pm Purchase | 2022-02-11 | 13G | Metacrine, Inc. MTCR | BML Investment Partners L.P. | 1,600,000 5.900% | 1,600,000![]() (New Position) | Filing |